Obstetrics and Gynaecology Short Flashcards
Summary of important topics
Breech presentation
When the presenting part of the foetus is the buttocks or feet
Most spontaneously correct to cephalic by 36 weeks
Offer external cephalic version (ECV) at 36 weeks if primiparous, 37 weeks if multiparous
Absolute contraindications: C-section indicated for any other reason, APH < 7 days, non-reassuring CTG, placental abruption or placenta praevia, uterine abnormality
Ovarian cancer
RIsk factors: unopposed exposure to oestrogen
Key features: abdominal discomfort, bloating, early satiety, urinary frequency/bowel habit changes
2ww if ascites, pelvic or abdominal mass (late signs)
Ix: combination of CA-125 (>35 IU/mL), pelvic ultrasound and menopausal status then CT staging and biopsy for histology
Stages:
- 1: confined to ovary
- 2: spread beyond ovary but within pelvis
- 3: spread beyond pelvis but within abdomen
- Spread beyond abdomen (distant metastasis
Mx: gynae oncology MDT, combination of surgery and chemotherapy
Endometrial cancer
Key features: PMB = endometrial cancer until proven otherwise, intermenstrual bleeding, pelvic pain, abdo discomfort/bloating, weight, anaemia
RFs: unopposed oestrogen e.g. PCOS, no or fewer pregnancies, early menarch, late menopause, obesity
Protective factors: mirena coil, COCP, multiparity, smoking
Dx: 1st line: TV USS, thickness >5mm = hysteroscopy and biopsy
Stage:
1- confined to uterus
2- to cervix
3- to ovaries, fallopian tubes or lymph nodes
4- bladder, rectum or beyond pelvis
Mx: radial hysterectomy with bilateral salping-oophorectomy (removal of uterus, cervix and adnexa)
Termination of pregnancy
- < 24 weeks gestation if elective
- Any gestation if risk to mother’s life,, risk of serious handicap, grave danger to mother’s physical/mental health
Medical:
Mifepristone (progesterone antagonist - stops pregnancy) and misoprostol (prostaglandin analogue to expel)
Surgical: vacuum aspiration or dilatation and curettage
Fat necrosis of the breast
Benign tumour caused by adipose tissue necrosis in the breast, common in obesity
Features: mimics malignancy - firm, irregular lump, inflamed/warm/red overlying skin
2WW criteria NICE
- > 30 with unexplained breast lump
- > 50 with nipple changes (skin changes, discharge, retraction)
Placental abruption
The detachment of the placenta from uterine wall. Obstetric emergency!
RFs: previous PA, pre-eclampsia, smoking, cocaine, maternal age > 35
Revealed: bleeding is seen from the vagina
Concealed: bleeding is hidden behind the placenta and no bleed externally
Key features: tense, firm, woody uterus. Foetal distress.
Dx: clinical dx, vital signs (BP, HR,RR, SpO2), bloods: FBC, U+E, LFTs, coagulation screen, group and save
Mx:
- Foetal distress or maternal compromise = emergency C-section
- No foetal distress or maternal compromise = induction of labour
Pre-eclampsia
New HTN in pregnant woman (140/90 or more) with proteinuria and end-organ dysfunction occurring after 20 weeks gestation.
RFs: high: existing HTN, SLE or SKD, previous pre-eclampsia, moderate: FHx, nulliparity, BMI 30 or more.
High risk = 1 high or 2 moderate
Key features: headache, vomiting, blurred vision, swelling of face, hands and feet
Dx: BP: 140/90 or more AND EITHER proteinuria (+1 on dipstick)), OR end-organ dysfunction (e.g. raised creatinine)) OR placental dysfunction (e.g. abnormal doppler)
Proteinuria = protein: creatinine > 30mg/mmol, or albumin: creatinine > 8mg/mmol
Mx: admit if 160/110 or more
Outpatient: 2x weekly FBC, LFTs and U+Es, BP monitoring at least every 48 hours, ultrasound monitoring of foetus, amniotic fluid and dopplers every 2 weeks, BP control <1350/85, offer medication if persistently 140/90 or over,
High risk = secondary care review + aspirin as prophylaxis from 12 weeks gestation
Labetalol as antihypertensive if established pre-eclampsia
Delivery: <34 weeks up to 37 weeks = monitor and deliver if foetal/ maternal compromise, give IV corticosteroids and Mg sulphate. > 37 weeks = delivery
Breast cancer type + risk factors
RFs: female (99%), BRCA 1 and 2 gene, FHx (first degree), more dense (glandular) tissue, obesity, smoking
- Ductal carcinoma in-situ (DCIS) - pre-cancerous originating from epithelial cells
- Lobular carcinoma in-situ (LCIS) - precancerous often in pre-menopausal women
- Invasive ductal carcinoma NST - most common type of invasive breast cancer, from breast ducts
- Invasive lobular carcinoma - 10%, from breast lobules
- Inflammatory breast disease - presents like mastitis or abscess. Warm, swollen, tender, peau d’orange skin, not responsive to abx
- Paget’s disease of the nipple - erythematous, scaly skin around the nipple/areola, presents like eczema. Often DCIS
Breast cancer investigations
NICE 2ww criteria:
> 30 with unexplained breast lump
50 with unexplained unilateral nipple changes
30 with unexplained lump in axilla
Breast clinic for triple assessment
- History and clinical examination
- Ultrasound (younger) or mammogram (older)
- Core biopsy and histology
Breast cancer management
- Wide local excision + radiotherapy
- Mastectomy with immediate or delayed reconstruction
- Neoadjuvant/adjuvant chemotherapy
Breast cancer receptors
- Oestrogen receptor (ER): tamoxifen for pre-menopausal, letrozole or anastrozole for post-menopausal
- Progesterone receptor (PR)
- Human epidermal growth factor (HER2) - Trastuzumab (cardiac monitoring needed)
Fibroadenoma
Highly mobile, firm, painless, well-circumscribed lump in the breast - “breast mouse”
Common in pre-menopausal women as they respond to oestrogen
Usually < 3cm
Menopause
Defined as at least 12 months after last menstrual period, the time leading up to menopause is peri-menopause
Symptoms: hot flushes, low mood, emotional liability, joint pain, reduced libido, vaginal dryness and atrophy
Dx: 45 or over = clinical, FSH for < 40 suspected premature ovarian failure or 40 - 45 with perimenopausal symptoms
FSH + LH high and oestrogen low
Mx: none, HRT, SSRI, CBT, vaginal oestrogen creams, vaginal moisturisers
Contraception: > 50 for one year after LMP, <50 for two years after LMP
Placenta praevia
Low-lying placenta (grade 1/2), placeta praevia is when it covers the internal os, usually detected at 20-week anomaly scan
RFs: previous C-section, multiparity, older maternal age, maternal smoking, uterine abnormalities e.g. fibroids)
Key feature: painless vaginal bleeding
Grade 1: encroaches internal os, but does not reach it
Grade 2: reaches internal os but does not cover it
Grade 3: partially covers
Grade 4: completely covers
Mx: monitor and repeat TV USS at 32 and 36 weeks
If 34 - 35+6 weeks - then corticosteroids in case of preterm delivery
Planned delivery considered at 36 - 37 weeks to reduce risk of APH
Emergency c-section might be needed, with blood transfusions, intrauterine balloon tamponade etc.
Ectopic pregnancy (definitely going to be in exams according to the guy who writes the exams)
When an embryo implants outside of the uterus, most commonly the ampulla of the fallopian tube.
RFs: previous ectopic, PID, previous surgery to fallopian tubes, intrauterine devices (coils), older age, smoking
Key features: all child-bearing age females with lower abdominal pain, think ectopic! Missed period, lower abdominal pain in either LIF or RIL, right shoulder tip pain, vaginal bleedingm cervical moption tenderness
Ix: urine beta-hCG, ultrasound to locate pregnancy
Positive pregnancy test + abdo pain/tenderness = referral to Early Pregnancy Assessment Unit
Management of ectopic pregnancy
Expectant management if
- Follow-up possible to ensure successful termination
- Unruptured
- B-hCG < 1500UI/L
- adnexal mass < 35mm
- No significant pain
- No visible heartbeat
Medical management with IM methotrexate same as expectant but:
- B-hCG < 5000 UI/L
- Confirmed absence of intrauterine pregnancy by USS
Surgical management with salpingotomy or salpingectomy if:
- Anyone that does not meet criteria for expectant or medical mx:
- Pain
- Visible heartbeat
- Adnexal mass > 35mm
- B-hCG > 5000UI
Urinary incontinence
Urge - uncontrollable need to urinate leading to involuntary leak of urine = overactivity of the detrusor muscle
Stress - urine leak during times of increased abdominal pressure e.g. laughing or coughing = weakness of pelvic floor
Mixed - mixture of both
Overflow - urinary retention leading to leakage from overflow of urine
RFs: perineal tears, post-menopausal status, multiparity, pelvic floor surgery, pelvic organ prolapse, neuro conditions e.g. MS
Dx: bladder diary, urine dipstick for infection, post-void residual bladder volume - scan to measure volume left after voiding
Mx: stress: avoid caffeine, pelvic floor exercises, lose weight, duloxetine (SNRI)
Urge: bladder retraining, oxybutynin (anticholinergic), Botox injections
Fibrocystic changes of the breast
When breast tissue becomes fibrous (hard and irregular) and cystic (fluid-filled), in response to differing levels of oestrogen and progesterone and fluctuates through the menstrual cycle.
Key features: lumpiness, pain/tenderness (mastalgia), fluctuations in breast size
Mx: supportive bra, NSAIDs, apply heat, avoid caffeine, tamoxifen or danazol under specialist
Polycystic ovarian syndrome
Rotterdam criteria:
- Anovulation/oligo-ovulation
- Hyperandrogenism (hirsutism, oligomenorrhoea and acne)
- polycystic ovaries or ovarian volume > 10cm3 on USS
Other features: acanthosis nigricans, obesity, sub/infertility, mood disorders
Insulin resistance is present, high levels of insulin contributes to halting follicular development and increase androgen production = worsening PCOS symptoms.
Dx: LH:FSH raised, testosterone: normal/slightly raised, fasting and OGTT for insulin resistance
Mx:
- Lifestyle changes
- Co-cyprindrol: reduces hirsutism and regulates menstruation
- COCP regulates menstrual cycle + endometrial cancer protection
- Metformin to regulate menstrual cycle and enhance fertility
- Clomiphene to induce ovulation if trying to conceive
Cervical cancer
HPV 16 and 18
90% squamous cell carcinoma
Risk factors: non-engagement with screening, sexual activity at younger age, multiple sexual partners, smoking, FHx, immunosuppression
Clinical features: non-specific, abnormal vaginal discharge, post-cortical bleeding, urinary/bowel changes, suprapubic pain.
O/E with speculum: white/red patches on cervix, pelvic mass
Dx: FBC (anaemia), LFTs (liver involvement), U+Es (renal involvement), colposcopy for biopsy and CT staging
Stages:
- confined to cervix
- spreads to uterus or upper 2/3 vagina
- spreads to pelvic wall or lower 1/3 vagina
- Bladder, rectum or beyond pelvis
Mx:
- Cervical intraepithelial neoplasia and early stage 1a: LLETZ
- Advanced but still early stage: radical trachelectomy (removal of cervix and surrounding tissue)
- Stage 1B - 2A: radical hysterectomy with local lymph node removal + chemo + radiotherapy
- Stage 2B - 4A: chemo and radiotherapy
- Stage 4B: palliative care with surgery, radiotherapy, chemo
What is cervical intraepithelial neoplasia
Grade of cervical epithelial dysplasia found on colposcopy, not to be confused with dyskaryosis on cervical screening.
CIN I: mild dysplasia affecting 1/3 thickness of epithelium, likely to return to normal without tx
CIN II: moderate dysplasia, affecting 2/3 thickness of epithelium, likely to progress to cancer if untreated
CIN III (cervical carcinoma in situ): severe dysplasia, very likely to progress to cancer if untreated
Miscarriage
RFs: previous miscarriage, older maternal age, maternal smoking and alcohol during pregnancy
Early = up to 12 weeks
Late = 12 - 24 weeks
Types of miscarriage
- Missed - foetus is no longer alive but no symptoms have occurred
- Threatened - mild vaginal bleeding +/- abdominal pain cervical os is closed and foetus is alive
- Inevitable - heavy vaginal bleeding + abdominal pain + clots, cervical os is open, leading to complete or incomplete miscarriage
- Complete - miscarriage has occurred with no products of conception left
- Incomplete - vaginal bleeding + abdominal pain, miscarriage occurred but retained products of conception
- Recurrent: 3 or more miscarriages before 24 weeks gestation
Dx and Mx of miscarriage
Dx: TV USS to confirm viability and check size, heartbeat and pole
Mx:
- Expectant: 1 - 2 weeks allowed for products to pass, repeat urine BhCG after 3 weeks
- Medical: misoprostol (prostaglandin analogue) orally or vaginal pessary: heavier bleed, pain, vomiting, diarrhoea
- Surgical: manual or electric vacuum aspiration, offer anti-D for women undergoing this
If no risks of heavy bleeding or infection = expectant management
If > 6 weeks with bleeding = refer to EPAU
Threatened - monitoring and analgesia (paracetamol)
Complete - counselling and analgesia (paracetamol)
Incomplete- medical/surgical (+curettage) + counselling + analgesia
Recurrent - find underlying cause (e.g. antiphospholipid syndrome)
Ovarian cyst
Fluid-filled sacs on ovaries, functional cysts respond to fluctuations in menstrual cycle = pre-menopausal women
Follicular cysts = most common
Post-menopause, cysts = Ix for ?malignancy
Key features, asymptomatic, pelvic pain, bloating, abdo fullness, palatable mass if large
Risks of ovarian torsion or rupture
Always keep ovarian cancer in mind, rule out red flags (bloating, early satiety, change in urinary/bowel habit, weight loss, ascites, lymphadenopathy , assess risk factors and protective factors
Mx:
Pre-menopausal:
- < 5cm = resolve within 3 cycles
- 5 - 7cm = routine gynae referral + yearly USS
- > 7cm - MRI scan or surgical evaluation
Post-menopausal:
- CA-125 and gynae referral
- Normal CA-125 and <5cm = USS every 4 - 6 months
- Abnormal CA-125 = gynae
- Growing cysts = surgical intervention (laparoscopic ovarian cystectomy +/- oophorectomy